István Láng
Researcher Next ID · RN-011712
Researcher · Biochemistry, Genetics and Molecular Biology
, Nigeria
- Works count
- 153
- Citation count
- 19,142
- H-index
- 44
- i10-index
- 77
Research interests
Publications
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
New England Journal of Medicine · 2017 · 10.1056/nejmoa1703643
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
The Lancet · 2015 · 10.1016/s0140-6736(15)00986-1
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
Journal of Clinical Oncology · 2011 · 10.1200/jco.2010.33.5091
Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98
Journal of Clinical Oncology · 2007 · 10.1200/jco.2006.08.8617
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
New England Journal of Medicine · 2005 · 10.1056/nejmoa052306
Current projects
No projects listed.